News

Press Releases

Mar 14, 2023

CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting

Mar 13, 2023

CRISPR Therapeutics Announces Transition of Chief Financial Officer

Feb 27, 2023

CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference

Feb 21, 2023

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Presentations

Sep 22, 2022

CRISPR Therapeutics Corporate Presentation

Jun 21, 2022

Innovation Day Presentation

Jun 12, 2022

EHA 2022 (Exa-cel)

Jun 11, 2022

2022 EHA Oral Presentation (CTX130 COLBALT-LYM)

View All Presentations

You are now leaving the CRISPR Therapeutics website.

CRISPR Therapeutics is not responsible for the content or availability of third-party sites.